Bath & Body Works (BBWI, Financials) shares surged nearly 10% on Tuesday after JPMorgan (JPM, Financials) upgraded the stock, citing an improved outlook for the company's sales and product expansion.
From "neutral," JPMorgan analysts rated the company as "overweight" and lifted the price objective to $47 from $41. Following a post-pandemic downturn, the company claimed demand for Bath & Body Works' basic productsincluding hand sanitizers and candleshas steadied. Analyzers think the worst of the sales drop is past and hope for more consistent performance moving forward.
With its biggest-ever Disney partnership, which includes 85 perfumed items inspired by Disney Princesses, Bath & Body Works is upgrading its product offers. Three times bigger than past collaborations, like Netflix-themed collections for "Bridgerton" and "Stranger Things," the new line is According to JPMorgan analysts, the cooperation may stimulate full-price sales, thereby increasing profits.
While maintaining a solid position in the fragrance and hand sanitizer categories, the company also observed that Bath & Body Works is still underpriced compared to other beauty and personal care firms. The stock update comes before the company's Feb. 27 fourth-quarter results.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.